-
公开(公告)号:EP3464244B1
公开(公告)日:2021-11-17
申请号:EP17730412.8
申请日:2017-05-31
IPC分类号: C07D219/02 , C07D333/76 , C07C211/00 , C07D405/04 , C07D417/04 , C07D209/86 , C07D307/91 , H01L51/50
-
公开(公告)号:EP3860561A1
公开(公告)日:2021-08-11
申请号:EP19789841.4
申请日:2019-09-27
发明人: JAYARAMAN, Muthusamy , HE, Guo , MAIER, Martin
IPC分类号: A61K9/00 , A61K9/127 , A61K31/7088 , C07C211/00 , C07C219/00 , C12N15/88 , C07D295/15
-
3.
公开(公告)号:EP2922812B1
公开(公告)日:2021-08-11
申请号:EP13856101.4
申请日:2013-10-29
IPC分类号: C10M159/20 , C07C43/20 , C07C211/00 , C10N30/04 , C10N30/00 , C10N70/00
-
公开(公告)号:EP3775099A1
公开(公告)日:2021-02-17
申请号:EP19713814.2
申请日:2019-04-01
申请人: Merck Patent GmbH
发明人: PARHAM, Amir , KROEBER, Jonas , GROSSMANN, Tobias , JATSCH, Anja , EICKHOFF, Christian , EHRENREICH, Christian , ENGELHART, Jens
IPC分类号: C09K11/06 , C07C211/00 , H01L51/50
-
公开(公告)号:EP3697400A1
公开(公告)日:2020-08-26
申请号:EP18869130.7
申请日:2018-10-18
申请人: Epizyme, Inc.
IPC分类号: A61K31/137 , A61P7/00 , C07C211/00 , C07C211/04
-
公开(公告)号:EP2619169B1
公开(公告)日:2018-09-12
申请号:EP11826511.5
申请日:2011-09-19
发明人: ANTEBI, Shlomo , FELDMAN, David
IPC分类号: C07C211/00 , A01N47/28 , A01N59/00 , A01P1/00 , C07C273/18
CPC分类号: C07C273/1863 , A01N33/08 , A01N47/28 , A01N59/00
摘要: The invention provides a process for manufacturing biocidal compositions containing bromourea derivatives, including the reaction of salts or adducts of the urea derivatives with an oxidizer.
-
7.
公开(公告)号:EP3331861A1
公开(公告)日:2018-06-13
申请号:EP16745129.3
申请日:2016-08-01
IPC分类号: C07D215/18 , C07D215/38 , C07C205/00 , C07C211/00
CPC分类号: C07D215/38 , C07C205/12 , C07C211/52 , C07C229/44 , C07D215/18 , C07D215/227
摘要: The present invention relates to a novel process for the preparation of 5-Amino-quinolin-2(1H)-ones and its tautomer's 5-amino-quinolin-2-ols. The present invention further comprises various novel compounds which are obtained during the preparation of 5-Amino-quinolin-2(1H)-ones and its tautomer's 5-amino-quinolin-2-ols.
-
公开(公告)号:EP3118205A4
公开(公告)日:2017-10-18
申请号:EP15762299
申请日:2015-03-03
发明人: NAGASHIMA HIDEO , SUNADA YUSUKE , OGUSHI HAJIME , SAKUTA KOJI
IPC分类号: C07F19/00 , B01J31/22 , C07B61/00 , C07C5/03 , C07C9/15 , C07C9/16 , C07C13/465 , C07C13/48 , C07C15/00 , C07C15/073 , C07C15/18 , C07C67/303 , C07C69/38 , C07C69/42 , C07C69/612 , C07C209/50 , C07C211/00 , C07C211/04 , C07F7/08 , C07F15/00
CPC分类号: B01J31/1608 , B01J2231/323 , B01J2231/645 , B01J2531/821 , C07C5/03 , C07C67/283 , C07C67/303 , C07C209/50 , C07C209/62 , C07C2531/16 , C07C2531/18 , C07C2601/14 , C07C2602/08 , C07F7/0829 , C07F7/0879 , C07F15/0046 , C07F15/0053 , C07F19/00 , C07C211/04 , C07C13/18 , C07C13/465 , C07C15/18 , C07C15/073 , C07C9/15 , C07C9/16 , C07C69/24 , C07C69/38 , C07C69/612
摘要: A neutral or cationic mononuclear ruthenium divalent complex represented by formula (1) can actualize exceptional catalytic activity in at least one reaction among a hydrosilylation reaction, hydrogenation reaction, and carbonyl compound reduction reaction. (In the formula, R 1 -R 6 each independently represent a hydrogen atom or an alkyl group, aryl group, aralkyl group, organooxy group, monoorganoamino group, diorganoamino group, monoorganophosphino group, diorganophosphino group, monoorganosilyl group, diorganosilyl group, triorganosilyl group, or organothio group optionally substituted by X; at least one pair comprising any of R 1 -R 3 and any of R 4 -R 6 together represents a crosslinkable substituent; X represents a halogen atom, organooxy group, monoorganoamino group, diorganoamino group, or organothio group; L each independently represent a two-electron ligand other than CO and thiourea ligands; two L may bond to each other; and m represents an integer of 3 or 4.)
-
公开(公告)号:EP3030323A1
公开(公告)日:2016-06-15
申请号:EP14834451.8
申请日:2014-08-06
IPC分类号: A61P35/02 , C07C211/00 , C07C237/00
CPC分类号: C07D295/192 , A61K31/166 , A61K31/40 , A61K31/4453 , A61K31/454 , A61K31/4545 , A61K31/47 , A61K31/495 , A61K31/5375 , A61K31/54 , C07C237/22 , C07C2601/02 , C07D213/81 , C07D215/14 , C07D233/90 , C07D295/185 , C07D295/26
摘要: Disclosed herein are new compounds and compositions and their application as pharmaceuticals for the treatment of diseases. Methods of inhibition of KDMIA, methods of increasing gamma globin gene expression, and methods to induce differentiation of cancer cells in a human or animal subject are also provided for the treatment of diseases such as acute myelogenous leukemia.
-
公开(公告)号:EP2880011A4
公开(公告)日:2016-03-23
申请号:EP13824974
申请日:2013-07-31
发明人: LEECH RONALD L
IPC分类号: C07C211/00
CPC分类号: B01J20/26 , B01J20/045 , B01J20/22 , B01J20/261 , B01J20/262 , B01J2220/44 , B01J2220/46 , B09B3/0008 , C09K21/14
-
-
-
-
-
-
-
-
-